Dopamine · larger labeled portfolio than Bromocriptine

SPL labels Dopamine + Bromocriptine as minor; Dopamine 23 / Bromocriptine 6 in that band.

Mechanism on file: These drugs can interfere with each other because they both target the dopamine system in the brain. This can make the treatment less effective or cause unwanted effects.

FDA SPL severity: Minor

Dopamine

Full Dopamine label record

Inotropic / Vasopressor

Bromocriptine

Full Bromocriptine label record

Dopamine Agonist (Diabetes)

Dopamine + Bromocriptine · SPL mechanism field

These drugs can interfere with each other because they both target the dopamine system in the brain. This can make the treatment less effective or cause unwanted effects.

Minor band excerpt · Dopamine with Bromocriptine

Bromocriptine mesylate may interact with dopamine antagonists, butyrophenones, and certain other agents.

Dopamine · 28 SPL pairs (broader portfolio than Bromocriptine)

View all Dopamine interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.